Nanjing King-Friend Biochemical Pharmaceutical (603707.SH): Rocuronium Bromide Injection Obtains Drug Registration Certificate.

Nanjing King-Friend Biochemical Pharmaceutical (603707.SH) announced that the company has recently received the drug registration certificate for Rocuronium Bromide Injection 5ml:50mg and 10ml:100mg issued by the National Medical Products Administration. Rocuronium Bromide Injection is used as an adjuvant for general anesthesia, to facilitate tracheal intubation during routine induction of anesthesia, and to maintain neuromuscular blockade of skeletal muscles during surgery.